Bedford Technology Park
About MologicMologic Ltd, which develops powerful, personalised diagnostics to improve the lives of patients.
Founders: Paul Davis and Mark Davis
Founder and CEO: Mark Davis
Tweets by Mologic
18 articles with Mologic
Biopharma and life sciences companies from across the globe provide updates on their pipelines and businesses.
Partnership to accelerate CE marking of Avacta’s SARS-CoV-2 rapid antigen test and support COVID-19 testing in low and middle income countries
5/14/2020Biopharma and life sciences companies from across the globe provide updates on their pipeline and business.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 11, 2020.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 20, 2020.
Grant awarded by the Wellcome Trust and DFID, as part of UK government’s £46 million international COVID-19 prevention and research package
2/27/2020Biopharma and life sciences companies from across the globe provide updates on their pipelines and business operations.
Observational, multi-centre validation trial carried out in collaboration with a consortium of leading clinicians and clinical centres
Sherlock Biosciences and Mologic Establish Strategic Partnership to Develop Instrument-free Molecular Diagnostic Tests
Collaboration facilitated by the Bill & Melinda Gates Foundation through an expansion of an existing grant to Mologic
Mologic and University College London Hospitals collaborating in major clinical trial for early detection of sepsis
Mologic Ltd announced that it has finished recruitment to a major clinical trial with University College London Hospitals (UCLH) to evaluate the Company’s point-of-care (POC) diagnostic test for the early detection of sepsis.
Companies from across the globe provide updates to their pipelines and businesses, with news from BioNTech, Mologic, Akcea, RedHill, and more.
Mologic achieves breakthrough in ultra-sensitive point-of-care diagnostics and develops new platform technology
Mologic Ltd, a leading developer of lateral flow and rapid diagnostic technologies, services and products, today announced it has completed the development of a next generation ultra-sensitive lateral flow-based technology platform. Initially being exemplified through the development of low cost, high performance devices for malaria and HIV, the novel diagnostics can be visually read and demonstrate up to a 1,000-fold improvement in sensitivity over current technology.
4/5/2019Pharma, biotech and life science companies strengthen leadership teams, with news from Vertex, Arvinas, Provention, Enterome, and more.
Mologic Ltd, a leading developer of lateral flow and rapid diagnostic technologies, services and products, today announced it has completed the latest phase of the Company’s expansion plans.
Mologic Ltd, a developer of powerful, personalised diagnostics to improve the lives of patients, today announced that it has commenced a clinical trial to evaluate the Company’s urine-based diagnostic, HeadsUp, in monitoring pulmonary exacerbation in cystic fibrosis (CF) patients.
Mologic Ltd announced that it has signed agreements with medical technology companies, Medisur and Peripal AG to distribute PERiPLEX®.
Mitch will use his skills and experience to help lead these changes and take products from conception through to manufacture and commercialisation.
Mologic Receives CE Mark Approval For Bvpro Point-Of-Care Diagnostic For Patients With Bacterial Vaginosis